These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32078414)

  • 1. Anti-Neutrophil Cytoplasmic Antibody-Associated Ocular Manifestations in Japan: A Review of 18 Patients.
    Miyanaga M; Takase H; Ohno-Matsui K
    Ocul Immunol Inflamm; 2021 Jul; 29(5):991-996. PubMed ID: 32078414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type.
    Unizony S; Villarreal M; Miloslavsky EM; Lu N; Merkel PA; Spiera R; Seo P; Langford CA; Hoffman GS; Kallenberg CM; St Clair EW; Ikle D; Tchao NK; Ding L; Brunetta P; Choi HK; Monach PA; Fervenza F; Stone JH; Specks U;
    Ann Rheum Dis; 2016 Jun; 75(6):1166-9. PubMed ID: 26621483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical Perinuclear Anti-Neutrophil Cytoplasmic Antibodies in Ocular Inflammatory Diseases.
    Ebrahimiadib N; Ma L; Modjtahedi BS; Davoudi S; Rahmani S; Syeda S; Stephenson A; Foster CS
    Ocul Immunol Inflamm; 2019; 27(6):937-941. PubMed ID: 30230931
    [No Abstract]   [Full Text] [Related]  

  • 4. Eye manifestations in patients with perinuclear antineutrophil cytoplasmic antibody-associated vasculitis: case series and literature review.
    Matsuo T
    Jpn J Ophthalmol; 2007; 51(2):131-8. PubMed ID: 17401624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of anti-neutrophil cytoplasmic antibodies in scleritis associated with Wegener's granulomatosis.
    Soukiasian SH; Foster CS; Niles JL; Raizman MB
    Ophthalmology; 1992 Jan; 99(1):125-32. PubMed ID: 1741124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Key advances in the clinical approach to ANCA-associated vasculitis.
    Kallenberg CG
    Nat Rev Rheumatol; 2014 Aug; 10(8):484-93. PubMed ID: 24980139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L43. Seropositive and negative ANCA-associated vasculitis, anti-MPO and PR3-vasculitis: different outcomes?
    Holle JU
    Presse Med; 2013 Apr; 42(4 Pt 2):616-9. PubMed ID: 23481358
    [No Abstract]   [Full Text] [Related]  

  • 8. Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Berti A; Warner R; Johnson K; Cornec D; Schroeder D; Kabat B; Langford CA; Hoffman GS; Fervenza FC; Kallenberg CGM; Seo P; Spiera R; St Clair EW; Brunetta P; Stone JH; Merkel PA; Specks U; Monach PA;
    Arthritis Rheumatol; 2018 Jul; 70(7):1114-1121. PubMed ID: 29693324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating the concomitance of anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitides and inflammatory bowel disease (IBD).
    Mumtaz S; Valecha J; Hochwald A; Berianu F; Majithia V; Abril A
    Semin Arthritis Rheum; 2024 Jun; 66():152452. PubMed ID: 38677223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertrophic pachymeningitis is a characteristic manifestation of granulomatosis with polyangiitis: A retrospective study of anti-neutrophil cytoplasmic antibody-associated vasculitis.
    Shimojima Y; Kishida D; Hineno A; Yazaki M; Sekijima Y; Ikeda SI
    Int J Rheum Dis; 2017 Apr; 20(4):489-496. PubMed ID: 28217942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics, the diagnostic criteria and management recommendation of otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV) proposed by Japan Otological Society.
    Harabuchi Y; Kishibe K; Tateyama K; Morita Y; Yoshida N; Okada M; Kunimoto Y; Watanabe T; Inagaki A; Yoshida T; Imaizumi M; Nakamura T; Matsunobu T; Kobayashi S; Iino Y; Murakami S; Takahashi H; Tono T
    Auris Nasus Larynx; 2021 Feb; 48(1):2-14. PubMed ID: 32768313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics of patients with vasculitis positive for anti-neutrophil cytoplasmic antibody targeting both proteinase 3 and myeloperoxidase: a retrospective study.
    Kim SM; Choi SY; Kim SY; Kim J
    Rheumatol Int; 2019 Nov; 39(11):1919-1926. PubMed ID: 31552433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term Outcomes of Rituximab Therapy in Ocular Granulomatosis with Polyangiitis: Impact on Localized and Nonlocalized Disease.
    Joshi L; Tanna A; McAdoo SP; Medjeral-Thomas N; Taylor SR; Sandhu G; Tarzi RM; Pusey CD; Lightman S
    Ophthalmology; 2015 Jun; 122(6):1262-8. PubMed ID: 25745876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteinase-3 antineutrophil cytoplasm antibody positivity in patients without primary systemic vasculitis.
    McAdoo SP; Hall A; Levy J; Salama AD; Pusey CD
    J Clin Rheumatol; 2012 Oct; 18(7):336-40. PubMed ID: 23047533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Reappearance of Myeloperoxidase-Antineutrophil Cytoplasmic Antibody and Relapse in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Subgroup Analysis of Nationwide Prospective Cohort Studies.
    Watanabe H; Sada KE; Matsumoto Y; Harigai M; Amano K; Dobashi H; Fujimoto S; Usui J; Yamagata K; Atsumi T; Banno S; Sugihara T; Arimura Y; Matsuo S; Makino H;
    Arthritis Rheumatol; 2018 Oct; 70(10):1626-1633. PubMed ID: 29790303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ANCA-associated vasculitis - clinical utility of using ANCA specificity to classify patients.
    Cornec D; Cornec-Le Gall E; Fervenza FC; Specks U
    Nat Rev Rheumatol; 2016 Oct; 12(10):570-9. PubMed ID: 27464484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloperoxidase-ANCA-positive granulomatosis with polyangiitis is a distinct subset of ANCA-associated vasculitis: A retrospective analysis of 455 patients from a single center in China.
    Chang DY; Li ZY; Chen M; Zhao MH
    Semin Arthritis Rheum; 2019 Feb; 48(4):701-706. PubMed ID: 29887327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgG anti-Pentraxin 3 antibodies are a novel biomarker of ANCA-associated vasculitis and better identify patients with eosinophilic granulomatosis with polyangiitis.
    Padoan R; Gatto M; Ghirardello A; Tonello M; Franco C; Felicetti M; Schiavon F; Doria A
    J Autoimmun; 2021 Nov; 124():102725. PubMed ID: 34534841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features and treatment outcomes of otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV): A retrospective analysis of 235 patients from a nationwide survey in Japan.
    Harabuchi Y; Kishibe K; Tateyama K; Morita Y; Yoshida N; Kunimoto Y; Matsui T; Sakaguchi H; Okada M; Watanabe T; Inagaki A; Kobayashi S; Iino Y; Murakami S; Takahashi H; Tono T
    Mod Rheumatol; 2017 Jan; 27(1):87-94. PubMed ID: 27166750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of interleukin-32 and interleukin-6 in granulomatosis with polyangiitis and microscopic polyangiitis: association with clinical and biochemical findings.
    Krajewska Wojciechowska J; Kościelska-Kasprzak K; Krajewski W; Morawski K
    Eur Cytokine Netw; 2019 Dec; 30(4):151-159. PubMed ID: 32096477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.